# REZZAYO

NDC: 70842-240
Generic name: rezafungin
Labeler / Manufacturer: Melinta Therapeutics, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20230609

FDA application: NDA217417

## Active ingredients

- REZAFUNGIN: 200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70842-240"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70842-240
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=90073508-6dca-4d27-aa5a-ed837737c35b